Cibc Bancorp Usa Inc. Dyne Therapeutics, Inc. Transaction History
Cibc Bancorp Usa Inc.
- $80.8 Billion
- Q3 2025
A detailed history of Cibc Bancorp Usa Inc. transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Cibc Bancorp Usa Inc. holds 11,641 shares of DYN stock, worth $217,453. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,641Holding current value
$217,453% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DYN
# of Institutions
220Shares Held
130MCall Options Held
36.5KPut Options Held
138K-
Vanguard Group Inc Valley Forge, PA9.76MShares$182 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA9.71MShares$181 Million2.02% of portfolio
-
Janus Henderson Group PLC London, X09.44MShares$176 Million0.05% of portfolio
-
Atlas Venture Life Science Advisors, LLC9.13MShares$171 Million26.07% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$138 Million0.01% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $967M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...